MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,130,630 | -15.6% | 113,063 | +4.9% | 0.00% | – |
| Q2 2023 | $1,339,990 | -13.6% | 107,803 | -2.6% | 0.00% | -100.0% |
| Q1 2023 | $1,550,921 | +4.8% | 110,701 | +7.1% | 0.00% | 0.0% |
| Q4 2022 | $1,479,612 | -42.7% | 103,397 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $2,582,000 | -14.3% | 101,142 | -4.6% | 0.00% | 0.0% |
| Q2 2022 | $3,012,000 | -14.2% | 105,991 | +6.5% | 0.00% | 0.0% |
| Q1 2022 | $3,510,000 | -15.3% | 99,526 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $4,144,000 | -7.1% | 98,915 | +8.8% | 0.00% | 0.0% |
| Q3 2021 | $4,462,000 | +123.0% | 90,913 | +89.6% | 0.00% | 0.0% |
| Q2 2021 | $2,001,000 | +569.2% | 47,956 | +471.7% | 0.00% | – |
| Q1 2021 | $299,000 | -43.9% | 8,389 | -55.9% | 0.00% | – |
| Q4 2020 | $533,000 | – | 19,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 24,612,474 | $1,027,079,000 | 28.61% |
| Avidity Partners Management LP | 2,963,545 | $123,669,000 | 3.34% |
| ELEMENT CAPITAL MANAGEMENT LLC | 376,545 | $15,713,000 | 2.48% |
| HealthCor Management, L.P. | 1,255,597 | $52,396,000 | 2.09% |
| Ownership Capital B.V. | 2,328,804 | $97,181,000 | 1.13% |
| Select Equity Group, L.P. | 7,844,892 | $327,367,343,000 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $3,756,000 | 0.82% |
| Champlain Investment Partners, LLC | 3,455,625 | $144,203,000 | 0.68% |
| First Light Asset Management, LLC | 202,138 | $8,435,000 | 0.51% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 73,579 | $3,070,000 | 0.47% |